Herbas VPB

Print
EN | LT
LT - Antikūnai prieš SARS-CoV-2
EN - ANTIBODIES AGAINST SARS-COV-2

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07K 16/10 (2006.01)
A61K 39/395 (2006.01)
A61P 31/14 (2006.01)
European patent
(11) Number of the document 3872091
(13) Kind of document T
(96) European patent application number 21159353.8
Date of filing the European patent application 2021-02-25
(97) Date of publication of the European application 2021-09-01
(45) Date of publication and mention of the grant of the patent 2023-06-14
(46) Date of publication of the claims translation 2023-10-10
Priority applications
(30) Number Date Country code
202062981984 P 2020-02-26 US
202062982661 P 2020-02-27 US
202062987298 P 2020-03-09 US
202062989522 P 2020-03-13 US
202062990369 P 2020-03-16 US
202062992082 P 2020-03-19 US
202062994235 P 2020-03-24 US
202063001204 P 2020-03-27 US
202063003214 P 2020-03-31 US
202063005206 P 2020-04-03 US
202063010589 P 2020-04-15 US
202063011971 P 2020-04-17 US
202063014024 P 2020-04-22 US
202063023788 P 2020-05-12 US
202063025133 P 2020-05-14 US
202063039813 P 2020-06-16 US
202063043653 P 2020-06-24 US
202063050331 P 2020-07-10 US
202063052810 P 2020-07-16 US
Inventors
(72)
LEMPP, Florian A. , US
TELENTI, Amalio , US
CORTI, Davide , CH
FINK, Katja , CH
BELTRAMELLO, Martina , CH
CAMERONI, Elisabetta , CH
PINTO, Dora , CH
SNELL, Gyorgy , US
Grantee
(73) VIR Biotechnology, Inc. , 1800 Owens Street Suite 900, San Francisco, CA 94158, US
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) Antikūnai prieš SARS-CoV-2
  ANTIBODIES AGAINST SARS-COV-2
Last renewal fee
Payment date Validity (years) Amount
2025-02-03 5 115.00 EUR
Next renewal fee
2026-02-25